| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2012/591654 |
| P953 | full work available online at | http://downloads.hindawi.com/journals/ecam/2012/591654.pdf |
| http://downloads.hindawi.com/journals/ecam/2012/591654.xml | ||
| https://downloads.hindawi.com/journals/ecam/2012/591654.pdf | ||
| https://europepmc.org/articles/PMC3478874 | ||
| https://europepmc.org/articles/PMC3478874?pdf=render | ||
| P932 | PMC publication ID | 3478874 |
| P698 | PubMed publication ID | 23118793 |
| P5875 | ResearchGate publication ID | 232766586 |
| P2093 | author name string | Hui Dong | |
| Li Zhao | |||
| Nan Wang | |||
| Fuer Lu | |||
| P2860 | cites work | Drug Research | Q10530143 |
| Complementary and alternative medicine: herbal therapies for diabetes | Q73823430 | ||
| Chinese Journal of Evidence-Based Medicine | Q96330465 | ||
| Journal of Clinical Research | Q15757145 | ||
| Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 | ||
| Efficacy of berberine in patients with type 2 diabetes mellitus | Q24645248 | ||
| Modern Hospital | Q27712154 | ||
| Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion | Q28578447 | ||
| Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature | Q29614233 | ||
| Chinese herbal medicines for type 2 diabetes mellitus | Q31097067 | ||
| Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats | Q33246062 | ||
| Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins | Q34552498 | ||
| The role of complementary and alternative medicine in diabetes | Q36560994 | ||
| Diabetes is an inflammatory disease: evidence from traditional Chinese medicines | Q37825944 | ||
| Pharmacological Management of Type 2 Diabetes Mellitus: An Update | Q37918574 | ||
| Berberine‐induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases | Q37946266 | ||
| Hypoglycemic agents in the management of type 2 diabetes mellitus | Q37954770 | ||
| Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression | Q39792130 | ||
| Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism | Q42146973 | ||
| Ondansetron and Metformin-Induced Gastrointestinal Side Effects | Q44659967 | ||
| Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine | Q46656835 | ||
| Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation | Q50703296 | ||
| Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats | Q51404403 | ||
| [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research] | Q68072355 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 591654 | |
| P577 | publication date | 2012-10-15 | |
| P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
| P1476 | title | Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis | |
| Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis | |||
| P478 | volume | 2012 |
| Q97887383 | A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer's Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment |
| Q33893257 | Antidiabetic and antioxidative effect of jiang tang xiao ke granule in high-fat diet and low-dose streptozotocin induced diabetic rats |
| Q35145862 | Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus |
| Q35226998 | Application of berberine on treating type 2 diabetes mellitus |
| Q64097026 | Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance |
| Q90355916 | Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome |
| Q51759774 | Berberine Ameliorates MCAO Induced Cerebral Ischemia/Reperfusion Injury via Activation of the BDNF-TrkB-PI3K/Akt Signaling Pathway |
| Q37622726 | Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats |
| Q38965186 | Berberine and Its Role in Chronic Disease |
| Q35239952 | Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL/6 mice |
| Q34366519 | Berberine suppresses gero-conversion from cell cycle arrest to senescence |
| Q38928488 | Berberis Vulgaris and Berberine: An Update Review |
| Q36183707 | Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis |
| Q88868465 | Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk |
| Q47110162 | Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats |
| Q55071906 | Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine. |
| Q42068899 | Effect of berberine on acetylcholine-induced atrial fibrillation in rabbit |
| Q90353941 | Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats |
| Q49647665 | Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial |
| Q61810313 | Enhanced Anti-diabetic Effect of Berberine Combined With Timosaponin B2 in Goto-Kakizaki Rats, Associated With Increased Variety and Exposure of Effective Substances Through Intestinal Absorption |
| Q60955679 | Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins |
| Q42689757 | Ethnopharmacological values of cassava and its potential for diabetes and dyslipidemia management: Knowledge survey and critical review of report |
| Q36801780 | Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds |
| Q37156548 | Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds |
| Q38156718 | Learning from berberine: Treating chronic diseases through multiple targets |
| Q37352875 | Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled trial |
| Q37238931 | Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine |
| Q28082736 | Metformin and metabolic diseases: a focus on hepatic aspects |
| Q92504240 | Migration and Proliferation Effects of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) and Thymoquinone (TQ) on In Vitro Wound Healing Models |
| Q34668089 | Mitochondrial dysfunction and insulin resistance: an update |
| Q26748558 | Novel nutraceutic therapies for the treatment of metabolic syndrome |
| Q30368908 | Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis. |
| Q26778562 | Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art |
| Q40054323 | Phytochemical Quantification and the In Vitro Acetylcholinesterase Inhibitory Activity of Phellodendron chinense and Its Components. |
| Q90054793 | Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases |
| Q34045439 | Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes. |
| Q55285286 | Polyphenols and their effects on diabetes management: A review. |
| Q51063904 | Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). |
| Q37337259 | Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. |
| Q60301489 | Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds |
| Q89914852 | Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia |
| Q37540885 | Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia |
| Q35112532 | Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor |
| Q92504214 | The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials |
| Q64354593 | The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine |
| Q26851917 | The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research |
| Q92638927 | The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial |
| Q51098047 | The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine |
| Q41916806 | The marketing of unproven drugs for diabetes and dyslipidaemia in India |
| Q28546885 | Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model |
| Q26829674 | Traditional Indian Medicines Used for the Management of Diabetes Mellitus |
| Q57177401 | Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis |
| Q88631509 | What has traditional Chinese medicine delivered for modern medicine? |
Search more.